Mankind Pharma Limited has informed the Exchange regarding a press release dated October 15, 2026, titled "Press Release titled Mankind Pharma to Acquire Majority Stake in Armed Cell Therapeutics, Marking Strategic Entry into Next-Generation CAR-T Therapies ".

Summary by 6ix AI

Mankind Pharma Ltd. has announced its decision to acquire a majority stake in Armed Cell Therapeutics, a biotechnology company focused on CAR-T therapies for cancer, as part of its strategic growth plan. This move is aimed at enhancing Mankind's capabilities in innovative cancer treatments and expanding its global pharmaceutical presence.

Written by 6ix AI from the company’s filing. How 6ix writes summaries